With litigation surrounding the blood thinner Xarelto in its infancy, some lawyers examining cases said the litigation could expand to mass-tort proportions while others said it’s too early to tell.

Xarelto, prescribed to patients with atrial fibrillation and pulmonary embolism, is alleged by plaintiffs to cause uncontrollable, and sometimes fatal, bleeding.